25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Annovis Bio Inc
Buy, Hold or Sell?

Let's analyze Annovis Bio Inc together

I guess you are interested in Annovis Bio Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Annovis Bio Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Annovis Bio Inc

I send you an email if I find something interesting about Annovis Bio Inc.

1. Quick Overview

1.1. Quick analysis of Annovis Bio Inc (30 sec.)










1.2. What can you expect buying and holding a share of Annovis Bio Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.36
Expected worth in 1 year
$0.38
How sure are you?
22.2%

+ What do you gain per year?

Total Gains per Share
$0.02
Return On Investment
0.8%

For what price can you sell your share?

Current Price per Share
$2.73
Expected price per share
$0 - $5.5
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Annovis Bio Inc (5 min.)




Live pricePrice per Share (EOD)
$2.73
Intrinsic Value Per Share
$-12.46 - $-14.49
Total Value Per Share
$-12.10 - $-14.12

2.2. Growth of Annovis Bio Inc (5 min.)




Is Annovis Bio Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$7m$18.9m-$20.4m-1,409.7%

How much money is Annovis Bio Inc making?

Current yearPrevious yearGrowGrow %
Making money-$3.1b-$14.1m-$3.1b-99.6%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Annovis Bio Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#647 / 925

Most Revenue
#853 / 925

Most Profit
#923 / 925

Most Efficient
#244 / 925
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Annovis Bio Inc?

Welcome investor! Annovis Bio Inc's management wants to use your money to grow the business. In return you get a share of Annovis Bio Inc.

First you should know what it really means to hold a share of Annovis Bio Inc. And how you can make/lose money.

Speculation

The Price per Share of Annovis Bio Inc is $2.73. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Annovis Bio Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Annovis Bio Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.36. Based on the TTM, the Book Value Change Per Share is $0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.30 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Annovis Bio Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-648.58-23,757.5%-162.51-5,952.7%-0.62-22.9%-32.74-1,199.1%-24.25-888.3%
Usd Book Value Change Per Share0.4516.6%0.010.2%-0.30-11.0%0.041.5%0.010.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.4516.6%0.010.2%-0.30-11.0%0.041.5%0.010.4%
Usd Price Per Share8.06-11.11-13.16-15.90-11.78-
Price to Earnings Ratio0.00--16.01--5.65--23.81--17.64-
Price-to-Total Gains Ratio17.82-28.82-62.35--43.84--43.84-
Price to Book Ratio22.23--39.51-16.34-7.63-5.65-
Price-to-Total Gains Ratio17.82-28.82-62.35--43.84--43.84-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.73
Number of shares366
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.010.04
Usd Total Gains Per Share0.010.04
Gains per Quarter (366 shares)1.9014.50
Gains per Year (366 shares)7.6257.99
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
108-205848
201560116106
3023140174164
4030220232222
5038300290280
6046380348338
7053460406396
8061540464454
9069620522512
10076700580570

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.027.00.00.0%0.031.00.00.0%
Book Value Change Per Share3.01.00.075.0%4.08.00.033.3%6.014.00.030.0%6.018.03.022.2%7.021.03.022.6%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.027.00.0%0.00.031.00.0%
Total Gains per Share3.01.00.075.0%4.08.00.033.3%6.014.00.030.0%6.018.03.022.2%7.021.03.022.6%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Annovis Bio Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.4520.005+8595%-0.299+166%0.040+1042%0.010+4345%
Book Value Per Share--0.362-0.074+120%0.973-63%0.897-60%0.614-41%
Current Ratio--2.6641.974+35%5.817-54%15.851-83%11.779-77%
Debt To Asset Ratio--0.5081.261-60%0.216+135%0.765-34%8.729-94%
Debt To Equity Ratio--1.0330.258+300%0.294+251%0.153+577%0.127+713%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--162397526.000211970360.250-23%268457825.000-40%342637366.211-53%342637366.211-53%
Eps---648.580-162.508-75%-0.625-100%-32.735-95%-24.251-96%
Ev To Ebitda Ratio---9.253-7.094-23%-10.191+10%-25.629+177%-25.629+177%
Ev To Sales Ratio--infinfnan%infnan%infnan%infnan%
Free Cash Flow Per Share---0.164-0.295+79%-0.401+144%-0.208+27%-0.156-5%
Free Cash Flow To Equity Per Share--0.4430.081+450%-0.232+152%150.775-100%111.685-100%
Gross Profit Margin--0.866-97.404+11350%1.000-13%-18.681+2258%-13.578+1668%
Intrinsic Value_10Y_max---14.486--------
Intrinsic Value_10Y_min---12.458--------
Intrinsic Value_1Y_max---1.232--------
Intrinsic Value_1Y_min---1.210--------
Intrinsic Value_3Y_max---3.869--------
Intrinsic Value_3Y_min---3.690--------
Intrinsic Value_5Y_max---6.707--------
Intrinsic Value_5Y_min---6.211--------
Market Cap53197326.000-195%157058772.000216394251.000-27%256340961.000-39%309772121.400-49%229460830.667-32%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio7.531-195%22.235-39.505+278%16.338+36%7.631+191%5.652+293%
Pe Ratio-0.001+66%-0.003-16.007+515121%-5.649+181728%-23.813+766375%-17.639+567659%
Price Per Share2.730-195%8.06011.105-27%13.155-39%15.897-49%11.776-32%
Price To Free Cash Flow Ratio-4.154+66%-12.265-9.637-21%-9.754-20%-27.663+126%-20.491+67%
Price To Total Gains Ratio6.035-195%17.81828.820-38%62.350-71%-43.838+346%-43.838+346%
Quick Ratio--2343.860586.709+299%4.037+57959%132.275+1672%98.011+2291%
Return On Assets---880.012-220.830-75%-0.773-100%-44.428-95%-33.126-96%
Return On Equity---1789.198-447.299-75%-1.060-100%-89.784-95%-66.518-96%
Total Gains Per Share--0.4520.005+8595%-0.299+166%0.040+1042%0.010+4345%
Usd Book Value--7063700.000-1448014.500+120%18965112.000-63%17478804.700-60%11957067.852-41%
Usd Book Value Change Per Share--0.4520.005+8595%-0.299+166%0.040+1042%0.010+4345%
Usd Book Value Per Share--0.362-0.074+120%0.973-63%0.897-60%0.614-41%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--162397526.000211970360.250-23%268457825.000-40%342637366.211-53%342637366.211-53%
Usd Eps---648.580-162.508-75%-0.625-100%-32.735-95%-24.251-96%
Usd Free Cash Flow---3201321.000-5743558.500+79%-7818497.500+144%-4055363.500+27%-3040366.407-5%
Usd Free Cash Flow Per Share---0.164-0.295+79%-0.401+144%-0.208+27%-0.156-5%
Usd Free Cash Flow To Equity Per Share--0.4430.081+450%-0.232+152%150.775-100%111.685-100%
Usd Market Cap53197326.000-195%157058772.000216394251.000-27%256340961.000-39%309772121.400-49%229460830.667-32%
Usd Price Per Share2.730-195%8.06011.105-27%13.155-39%15.897-49%11.776-32%
Usd Profit---12638357000.000-3166664438.250-75%-14179610.000-100%-638277165.000-95%-472853588.704-96%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share--0.4520.005+8595%-0.299+166%0.040+1042%0.010+4345%
 EOD+2 -6MRQTTM+18 -15YOY+13 -205Y+13 -2010Y+10 -23

3.3 Fundamental Score

Let's check the fundamental score of Annovis Bio Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.001
Price to Book Ratio (EOD)Between0-17.531
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12,343.860
Current Ratio (MRQ)Greater than12.664
Debt to Asset Ratio (MRQ)Less than10.508
Debt to Equity Ratio (MRQ)Less than11.033
Return on Equity (MRQ)Greater than0.15-1,789.198
Return on Assets (MRQ)Greater than0.05-880.012
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Annovis Bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5023.710
Ma 20Greater thanMa 503.932
Ma 50Greater thanMa 1004.697
Ma 100Greater thanMa 2006.404
OpenGreater thanClose2.650
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Annovis Bio Inc

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead product candidate is Buntanetap, which has completed three Phase 1/2 clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, and other chronic neurodegenerative diseases. It is also developing ANVS405, which is in Phase 2 and Phase 3 efficacy studies, an intravenous drug for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials, an orally administered drug to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Malvern, Pennsylvania.

Fundamental data was last updated by Penke on 2025-02-08 08:07:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Annovis Bio Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Annovis Bio Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Annovis Bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--100.3%+100.3%
TTM--211.5%+211.5%
YOY--213.8%+213.8%
5Y--346.2%+346.2%
10Y--489.2%+489.2%
4.3.1.2. Return on Assets

Shows how efficient Annovis Bio Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Annovis Bio Inc to the Biotechnology industry mean.
  • -88,001.2% Return on Assets means that Annovis Bio Inc generated $-880.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Annovis Bio Inc:

  • The MRQ is -88,001.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -22,083.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-88,001.2%TTM-22,083.0%-65,918.2%
TTM-22,083.0%YOY-77.3%-22,005.6%
TTM-22,083.0%5Y-4,442.8%-17,640.2%
5Y-4,442.8%10Y-3,312.6%-1,130.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-88,001.2%-12.0%-87,989.2%
TTM-22,083.0%-12.1%-22,070.9%
YOY-77.3%-11.4%-65.9%
5Y-4,442.8%-12.8%-4,430.0%
10Y-3,312.6%-14.6%-3,298.0%
4.3.1.3. Return on Equity

Shows how efficient Annovis Bio Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Annovis Bio Inc to the Biotechnology industry mean.
  • -178,919.8% Return on Equity means Annovis Bio Inc generated $-1,789.20 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Annovis Bio Inc:

  • The MRQ is -178,919.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -44,729.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-178,919.8%TTM-44,729.9%-134,189.8%
TTM-44,729.9%YOY-106.0%-44,624.0%
TTM-44,729.9%5Y-8,978.4%-35,751.6%
5Y-8,978.4%10Y-6,651.8%-2,326.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-178,919.8%-15.4%-178,904.4%
TTM-44,729.9%-16.2%-44,713.7%
YOY-106.0%-14.7%-91.3%
5Y-8,978.4%-18.6%-8,959.8%
10Y-6,651.8%-19.5%-6,632.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Annovis Bio Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Annovis Bio Inc is operating .

  • Measures how much profit Annovis Bio Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Annovis Bio Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Annovis Bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--201.5%+201.5%
TTM--313.4%+313.4%
YOY--215.2%+215.2%
5Y--371.8%+371.8%
10Y--492.1%+492.1%
4.3.2.2. Operating Ratio

Measures how efficient Annovis Bio Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Annovis Bio Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.139-2.139
TTM-3.198-3.198
YOY-3.358-3.358
5Y-4.842-4.842
10Y-6.500-6.500
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Annovis Bio Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Annovis Bio Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.66 means the company has $2.66 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Annovis Bio Inc:

  • The MRQ is 2.664. The company is able to pay all its short-term debts. +1
  • The TTM is 1.974. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.664TTM1.974+0.689
TTM1.974YOY5.817-3.843
TTM1.9745Y15.851-13.877
5Y15.85110Y11.779+4.072
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6643.610-0.946
TTM1.9743.871-1.897
YOY5.8174.609+1.208
5Y15.8515.977+9.874
10Y11.7796.216+5.563
4.4.3.2. Quick Ratio

Measures if Annovis Bio Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Annovis Bio Inc to the Biotechnology industry mean.
  • A Quick Ratio of 2,343.86 means the company can pay off $2,343.86 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Annovis Bio Inc:

  • The MRQ is 2,343.860. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 586.709. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2,343.860TTM586.709+1,757.151
TTM586.709YOY4.037+582.672
TTM586.7095Y132.275+454.433
5Y132.27510Y98.011+34.264
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2,343.8603.085+2,340.775
TTM586.7093.360+583.349
YOY4.0374.400-0.363
5Y132.2755.972+126.303
10Y98.0116.483+91.528
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Annovis Bio Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Annovis Bio Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Annovis Bio Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.51 means that Annovis Bio Inc assets are financed with 50.8% credit (debt) and the remaining percentage (100% - 50.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Annovis Bio Inc:

  • The MRQ is 0.508. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 1.261. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ0.508TTM1.261-0.753
TTM1.261YOY0.216+1.045
TTM1.2615Y0.765+0.496
5Y0.76510Y8.729-7.963
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5080.341+0.167
TTM1.2610.343+0.918
YOY0.2160.315-0.099
5Y0.7650.363+0.402
10Y8.7290.384+8.345
4.5.4.2. Debt to Equity Ratio

Measures if Annovis Bio Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Annovis Bio Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 103.3% means that company has $1.03 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Annovis Bio Inc:

  • The MRQ is 1.033. The company is able to pay all its debts with equity. +1
  • The TTM is 0.258. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ1.033TTM0.258+0.775
TTM0.258YOY0.294-0.036
TTM0.2585Y0.153+0.106
5Y0.15310Y0.127+0.026
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0330.386+0.647
TTM0.2580.429-0.171
YOY0.2940.391-0.097
5Y0.1530.450-0.297
10Y0.1270.495-0.368
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Annovis Bio Inc generates.

  • Above 15 is considered overpriced but always compare Annovis Bio Inc to the Biotechnology industry mean.
  • A PE ratio of 0.00 means the investor is paying $0.00 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Annovis Bio Inc:

  • The EOD is -0.001. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.003. Based on the earnings, the company is expensive. -2
  • The TTM is -16.007. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.001MRQ-0.003+0.002
MRQ-0.003TTM-16.007+16.004
TTM-16.007YOY-5.649-10.358
TTM-16.0075Y-23.813+7.806
5Y-23.81310Y-17.639-6.174
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.001-2.247+2.246
MRQ-0.003-2.706+2.703
TTM-16.007-3.253-12.754
YOY-5.649-3.392-2.257
5Y-23.813-6.132-17.681
10Y-17.639-6.735-10.904
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Annovis Bio Inc:

  • The EOD is -4.154. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -12.265. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -9.637. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.154MRQ-12.265+8.111
MRQ-12.265TTM-9.637-2.628
TTM-9.637YOY-9.754+0.117
TTM-9.6375Y-27.663+18.026
5Y-27.66310Y-20.491-7.172
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.154-3.026-1.128
MRQ-12.265-3.582-8.683
TTM-9.637-3.816-5.821
YOY-9.754-4.463-5.291
5Y-27.663-8.265-19.398
10Y-20.491-9.266-11.225
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Annovis Bio Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 22.23 means the investor is paying $22.23 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Annovis Bio Inc:

  • The EOD is 7.531. Based on the equity, the company is overpriced. -1
  • The MRQ is 22.235. Based on the equity, the company is expensive. -2
  • The TTM is -39.505. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD7.531MRQ22.235-14.704
MRQ22.235TTM-39.505+61.740
TTM-39.505YOY16.338-55.843
TTM-39.5055Y7.631-47.136
5Y7.63110Y5.652+1.978
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD7.5311.948+5.583
MRQ22.2352.223+20.012
TTM-39.5052.427-41.932
YOY16.3382.469+13.869
5Y7.6313.767+3.864
10Y5.6524.507+1.145
4.6.2. Total Gains per Share

2.4. Latest News of Annovis Bio Inc

Does Annovis Bio Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Annovis Bio Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-02-07
14:00
Annovis to Present at Oppenheimer's 35th Annual Healthcare Life Sciences ConferenceRead
2025-02-04
22:31
Annovis Bio, Inc. Announces Closing of $21 Million Public OfferingRead
2025-02-01
02:14
Annovis Bio, Inc. Announces Proposed Public OfferingRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Annovis Bio Inc.

4.8.1. Institutions holding Annovis Bio Inc

Institutions are holding 6.652% of the shares of Annovis Bio Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30Vanguard Group Inc2.7560.0001380255189015.2306
2024-09-30Citadel Advisors Llc0.74430.00021026921026920
2024-09-30BlackRock Inc0.735601014957860.7805
2024-09-30Geode Capital Management, LLC0.71840.0001991142288130.0146
2024-12-31Merit Financial Group, LLC0.7140.00899851671816268.9738
2024-09-30Group One Trading, LP0.38240.001252767527670
2024-09-30Quest Partners LLC0.33340.03346002460020
2024-09-30Wescott Financial Advisory Group, LLC0.30160.03614160700
2024-09-30State Street Corp0.2612036035690023.6829
2024-09-30Sterling Investment Advisors Ltd0.24990.07043447410002.9874
2024-09-30Susquehanna International Group, LLP0.2285031520315200
2024-09-30D. E. Shaw & Co LP0.17690.000224410244100
2024-09-30Bridgeway Capital Management, LLC0.16020.00392210000
2024-09-30Northern Trust Corp0.159021934269914.0317
2024-09-30Jane Street Group LLC0.14640202061008399.6049
2024-09-30Spears Abacus Advisors LLC0.1450.003220000500033.3333
2024-09-30Bank of New York Mellon Corp0.138101905900
2024-09-30Greenwich Wealth Management LLC0.11940.00911647514009.2869
2024-09-30Bank of Montreal0.09780.000113500135000
2024-09-30BMO Capital Markets Corp.0.09780.000113500135000
Total 8.66590.16661195661+425857+35.6%

4.9.2. Funds holding Annovis Bio Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-12-31Vanguard Total Stock Mkt Idx Inv2.39550.000133050700
2024-12-31Vanguard Institutional Extnd Mkt Idx Tr0.94030.000612973900
2024-12-31Fidelity Extended Market Index0.39540.000754553-440-0.8001
2024-09-30Bridgeway Ultra-Small Company Market0.15220.09672100000
2025-01-29iShares Micro-Cap ETF0.14110.00981946900
2024-12-31Fidelity Total Market Index0.13010.00011794400
2024-12-31Fidelity Series Total Market Index0.09210.000112704-363-2.778
2024-12-31Northern Trust Extended Eq Market Idx0.0850.000711725166816.5855
2024-12-31NT Ext Equity Mkt Idx Fd - L0.0850.000711725166816.5855
2024-12-31Extended Equity Market Fund K0.08330.000411495-158-1.3559
2024-12-31Spartan Extended Market Index Pool E0.06080.000783894405.5353
2024-12-31Spartan Total Market Index Pool E0.04250.0001586900
2024-12-31T. Rowe Price Extended Equity Market Idx0.03480.0024480000
2024-12-31Vanguard Balanced Index Inv0.02970410000
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T30.02030.0007279427940
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T40.02030.0007279427940
2024-12-31NT Ext Equity Mkt Idx Fd - NL0.01850.0002255800
2024-12-31U.S. Equity Market Fund F0.01570.00012167-1-0.0461
2024-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.01470.00022027-33-1.6019
2024-12-31Vanguard U.S. Eq Idx £ Acc0.0140.0001193100
Total 4.77130.1151658290+8369+1.3%

5.3. Insider Transactions

Insiders are holding 14.446% of the shares of Annovis Bio Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2021-10-11Claudine BruckBUY18127.66
2021-10-11Maria-luisa MaccecchiniBUY1800027.61
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets14,362
Total Liabilities7,298
Total Stockholder Equity7,064
 As reported
Total Liabilities 7,298
Total Stockholder Equity+ 7,064
Total Assets = 14,362

Assets

Total Assets14,362
Total Current Assets14,362
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 12,637
Short-term Investments 12,623,993
Total Current Assets  (as reported)14,362
Total Current Assets  (calculated)12,636,630
+/- 12,622,268
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities5,391
Long-term Liabilities1,907
Total Stockholder Equity7,064
Total Current Liabilities
Accounts payable 4,099
Other Current Liabilities 1,292
Total Current Liabilities  (as reported)5,391
Total Current Liabilities  (calculated)5,391
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)1,907
Long-term Liabilities  (calculated)0
+/- 1,907
Total Stockholder Equity
Common Stock1
Retained Earnings -128,985
Other Stockholders Equity 136,047
Total Stockholder Equity (as reported)7,064
Total Stockholder Equity (calculated)7,064
+/-0
Other
Capital Stock1
Cash and Short Term Investments 12,637
Common Stock Shares Outstanding 12,976
Liabilities and Stockholders Equity 14,362
Net Debt -12,637
Net Invested Capital 7,064
Net Working Capital 8,970



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312013-09-302013-06-302013-03-312012-12-31
> Total Assets 
2,835
2,613
2,185
1,926
0
0
0
51
431
300
380
1,117
11,441
10,201
9,402
8,119
5,965
49,496
47,650
46,001
43,297
36,525
32,487
36,022
25,547
22,816
10,223
10,208
7,813
5,046
14,362
14,3625,0467,81310,20810,22322,81625,54736,02232,48736,52543,29746,00147,65049,4965,9658,1199,40210,20111,4411,117380300431510001,9262,1852,6132,835
   > Total Current Assets 
1,593
1,478
1,145
986
0
0
0
51
400
149
99
748
11,441
10,201
9,402
8,119
5,965
49,496
47,650
46,001
43,297
36,525
32,487
36,022
25,547
22,816
10,223
10,208
7,813
5,046
14,362
14,3625,0467,81310,20810,22322,81625,54736,02232,48736,52543,29746,00147,65049,4965,9658,1199,40210,20111,44174899149400510009861,1451,4781,593
       Cash And Cash Equivalents 
72
164
121
28
0
0
0
35
337
105
56
2
11,120
9,763
8,841
8,075
5,603
49,224
47,455
45,686
42,669
35,974
31,987
28,378
16,759
15,725
6,355
5,755
3,137
3,998
12,637
12,6373,9983,1375,7556,35515,72516,75928,37831,98735,97442,66945,68647,45549,2245,6038,0758,8419,76311,120256105337350002812116472
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,623,993
12,623,993000000000000000000000000000000
       Net Receivables 
1,474
1,255
981
919
0
0
0
0
0
0
0
735
38
199
425
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000004251993873500000009199811,2551,474
       Inventory 
23
22
21
20
0
0
0
0
0
0
0
0
278
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000002780000000020212223
       Other Current Assets 
24
38
23
19
0
0
0
16
64
45
42
11
5
239
136
45
362
272
195
315
628
551
500
7,644,376
8,788,597
26
3,868
42
315
313
1,725
1,725313315423,868268,788,5977,644,376500551628315195272362451362395114245641600019233824
   > Long-term Assets 
0
0
0
0
0
0
0
0
31
151
281
370
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000003702811513100000000
       Property Plant Equipment 
65
63
64
64
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000064646365
       Intangible Assets 
1,177
1,071
976
876
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000008769761,0711,177
       Other Assets 
0
0
0
0
0
0
0
0
31
151
281
370
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,048,688
1,724,946
1,724,9461,048,688000000000000000003702811513100000000
> Total Liabilities 
174
105
102
216
0
0
0
7,645
8,207
8,421
8,755
9,694
749
703
281
578
1,597
884
1,121
1,507
1,256
1,299
2,527
7,699
5,411
2,074
3,565
17,959
11,167
6,797
7,298
7,2986,79711,16717,9593,5652,0745,4117,6992,5271,2991,2561,5071,1218841,5975782817037499,6948,7558,4218,2077,645000216102105174
   > Total Current Liabilities 
174
105
102
216
0
0
0
568
608
794
1,126
2,011
749
703
281
578
1,597
884
1,121
1,507
1,256
1,299
2,527
7,699
5,411
2,074
3,565
4,279
4,870
4,057
5,391
5,3914,0574,8704,2793,5652,0745,4117,6992,5271,2991,2561,5071,1218841,5975782817037492,0111,126794608568000216102105174
       Accounts payable 
174
105
102
216
0
0
0
68
10
0
425
1,234
55
124
140
342
825
115
290
688
929
902
1,846
3,961
4,153
1,173
1,926
1,293
4,107
3,395
4,099
4,0993,3954,1071,2931,9261,1734,1533,9611,846902929688290115825342140124551,23442501068000216102105174
       Other Current Liabilities 
0
0
0
0
0
0
0
500
598
794
701
777
695
578
141
237
772
769
831
818
327
398
681
3,737
1,258
901
1,638
2,986
763
663
1,292
1,2926637632,9861,6389011,2583,7376813983278188317697722371415786957777017945985000000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
7,077
7,599
7,627
7,628
7,683
0
0
0
0
0
0
0
688
929
902
1,846
3,961
4,152,940
0
0
13,680
6,297
2,740
1,907
1,9072,7406,29713,680004,152,9403,9611,84690292968800000007,6837,6287,6277,5997,0770000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
496
497
498
500
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000050049849749600000000
       Other Liabilities 
0
0
0
0
0
0
0
0
27
53
53
106
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000010653532700000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
31
151
281
370
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000003702811513100000000
> Total Stockholder Equity
2,661
2,507
2,083
1,710
0
0
0
-7,594
-7,776
-8,121
-8,375
-8,576
10,692
9,498
9,121
7,541
4,368
48,612
46,530
44,495
42,040
35,226
29,961
28,324
20,136
20,743
6,658
-7,751
-3,354
-1,751
7,064
7,064-1,751-3,354-7,7516,65820,74320,13628,32429,96135,22642,04044,49546,53048,6124,3687,5419,1219,49810,692-8,576-8,375-8,121-7,776-7,5940001,7102,0832,5072,661
   Common Stock
57
57
57
57
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
11111111111111111110000000057575757
   Retained Earnings Total Equity00000-73,329-63,7920-50,960-43,3390-28,726-22,812-19,963-17,439-14,239000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
201
201
201
201
19,910
0
0
21,779
21,806
68,575
69,341
73,220
0
78,564
80,920
0
83,927
94,071
0
0
0
0
0
0000094,07183,927080,92078,564073,22069,34168,57521,80621,7790019,91020120120120100000000
   Treasury Stock0000000000000000000000000000000
   Other Stockholders Equity 
1,267
1,262
1,240
1,250
0
0
0
192
201
201
201
201
19,910
21,026
21,655
21,779
21,806
68,575
69,341
73,220
76,660
78,564
80,920
82,377
83,927
94,071
94,703
102,507
107,971
114,594
136,047
136,047114,594107,971102,50794,70394,07183,92782,37780,92078,56476,66073,22069,34168,57521,80621,77921,65521,02619,9102012012012011920001,2501,2401,2621,267



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-45,035
Operating Income-45,035-45,035
 
Operating Expense (+$)
Research Development38,791
Selling General Administrative6,244
Selling And Marketing Expenses6,238,164
Operating Expense45,0356,283,199
 
Net Interest Income (+$)
Interest Income676
Interest Expense-0
Other Finance Cost-0
Net Interest Income676
 
Pretax Income (+$)
Operating Income-45,035
Net Interest Income676
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-56,204-33,866
EBIT - interestExpense = -45,035
-56,249
-56,204
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-45,035-56,204
Earnings Before Interest and Taxes (EBITDA)-45,035
 
After tax Income (+$)
Income Before Tax-56,204
Tax Provision-0
Net Income From Continuing Ops-41,717-56,204
Net Income-56,204
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses45,035
Total Other Income/Expenses Net-11,169-676
 

Technical Analysis of Annovis Bio Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Annovis Bio Inc. The general trend of Annovis Bio Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Annovis Bio Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Annovis Bio Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 4.21 < 4.61 < 5.5.

The bearish price targets are: .

Tweet this
Annovis Bio Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Annovis Bio Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Annovis Bio Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Annovis Bio Inc. The current macd is -0.70290975.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Annovis Bio Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Annovis Bio Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Annovis Bio Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Annovis Bio Inc Daily Moving Average Convergence/Divergence (MACD) ChartAnnovis Bio Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Annovis Bio Inc. The current adx is 39.57.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Annovis Bio Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Annovis Bio Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Annovis Bio Inc. The current sar is 3.88269741.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Annovis Bio Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Annovis Bio Inc. The current rsi is 23.71. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 2/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending up: The RSI is trending up. +1
Annovis Bio Inc Daily Relative Strength Index (RSI) ChartAnnovis Bio Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Annovis Bio Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Annovis Bio Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Annovis Bio Inc Daily Stochastic Oscillator ChartAnnovis Bio Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Annovis Bio Inc. The current cci is -79.10862862.

Annovis Bio Inc Daily Commodity Channel Index (CCI) ChartAnnovis Bio Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Annovis Bio Inc. The current cmo is -56.81082788.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Annovis Bio Inc Daily Chande Momentum Oscillator (CMO) ChartAnnovis Bio Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Annovis Bio Inc. The current willr is -88.71940542.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Annovis Bio Inc Daily Williams %R ChartAnnovis Bio Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Annovis Bio Inc.

Annovis Bio Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Annovis Bio Inc. The current atr is 0.34142807.

Annovis Bio Inc Daily Average True Range (ATR) ChartAnnovis Bio Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Annovis Bio Inc. The current obv is 44,458,707.

Annovis Bio Inc Daily On-Balance Volume (OBV) ChartAnnovis Bio Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Annovis Bio Inc. The current mfi is 10.76.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Annovis Bio Inc Daily Money Flow Index (MFI) ChartAnnovis Bio Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Annovis Bio Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-09-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-14BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-21RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-11-22MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-11-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-12-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-16BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-12-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-19BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-12-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-13MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-27MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-06MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-12STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Annovis Bio Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Annovis Bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5023.710
Ma 20Greater thanMa 503.932
Ma 50Greater thanMa 1004.697
Ma 100Greater thanMa 2006.404
OpenGreater thanClose2.650
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Annovis Bio Inc with someone you think should read this too:
  • Are you bullish or bearish on Annovis Bio Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Annovis Bio Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Annovis Bio Inc

I send you an email if I find something interesting about Annovis Bio Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Annovis Bio Inc.

Receive notifications about Annovis Bio Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.